Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer
Status unconfirmed · Phase 2
Conditions studied: Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Colony-stimulating factors such as filgrastim may increase the number of immune cells found in bone marrow or peripheral blood and may help a person's immune system recover from the side effects of chemotherapy. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy with gemcitabine and docetaxel plus filgrastim in treating patients who have locally recurrent or advanced urothelium cancer.
Key facts
- Study ID
- NCT00005958
- Run by
- Amgen
- Starts
- 1999-10-01
- Last updated by the study team
- 2013-12-04
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of California San Diego — La Jolla, California, United States
- Sacramento Center for Hematology and Medical Oncology — Sacramento, California, United States
- Washington Cancer Institute — Washington D.C., District of Columbia, United States
- Center for Hematology-Oncology — Boca Raton, Florida, United States
- Oncology-Hematology Associates of North Illinois, Ltd. — Gurnee, Illinois, United States
- Maine Center for Cancer Medicine and Blood Disorders — Scarborough, Maine, United States
- St. Joseph Medical Center — Towson, Maryland, United States
- Hematology & Oncology Associates of Southern Michigan — Jackson, Michigan, United States
- Hematology Oncology Associates of Central New York — Syracuse, New York, United States
- Memphis Cancer Center, Inc. — Memphis, Tennessee, United States
- Arlington Cancer Center — Arlington, Texas, United States
- Northern Virginia Oncology Group — Fairfax, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.